Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
about
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsMultifunctional DDX3: dual roles in various cancer development and its related signaling pathwaysRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerEMT-Inducing Molecular Factors in Gynecological CancersThe Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal MetastasisMolecular pathways: trafficking of metabolic resources in the tumor microenvironmentThe Role of Mesothelial Cells in Liver Development, Injury, and RegenerationCooperative effects of fibronectin matrix assembly and initial cell-substrate adhesion strength in cellular self-assembly.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFRQuantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.Pathophysiological role of microRNA-29 in pancreatic cancer stromaMicroenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.Role of EGFR expression levels in the regulation of integrin function by EGF.Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal CavityPeritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer.Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signaling.Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.Ovarian cancer stem cells: still an elusive entity?Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis.Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic TargetingThe Unique Molecular and Cellular Microenvironment of Ovarian CancerPotential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells.Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers.Ovarian and Breast Cancer Migration Dynamics on Laminin and Fibronectin Bidirectional Gradient Fibers Fabricated via Multiphoton Excited Photochemistry.Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice.
P2860
Q26738643-764AA9B7-EC04-4307-9C1A-0327C5D12981Q26749143-26AE173F-1C4D-464D-8EA8-96B48343C16DQ26780387-B3DDC4C9-F8E5-41D4-8631-334E3B8A7EB4Q26781912-5CA7C327-A511-45E1-B319-98D1056ACA74Q26783022-04635EAC-8C02-47E6-B089-1603CA556737Q26825620-4A7E58CE-F145-45B2-8E34-DCDE5736636BQ28066412-38F15213-99AD-4D00-A3BC-E304D19C345CQ30712164-DF72B493-5661-448E-9847-6B73FE272590Q33361929-AB2ACE62-B252-4CE9-8A6E-9044AA38986EQ33624680-E19504DF-DC3E-423F-879D-4158B8CFB2B1Q33788703-75417B7D-10D2-42ED-BA69-A9C83FEC03FCQ33835932-49E0E4F9-FA3B-4D68-9722-DCF5B03BD464Q35592860-4530913A-2263-4B78-ACA0-6DCEDE35BF59Q35765000-EC06BFCD-E40F-428E-A631-DA618BB84CB8Q36086967-68783F28-D629-411C-BA27-89090FC2BB98Q36088140-9B5F05A8-EDDE-4BE8-9659-2D0FF53AD312Q36122605-69BF7BEE-88D0-4FE5-8D44-DC1D072E9465Q36180735-6DD0DDAE-00F9-4098-ACDD-E6DFB75312D3Q36348380-0F642E6E-4AB7-4012-AC10-257045634CF8Q36659620-BBFE479B-BCFC-4E98-A92A-16CE944256B4Q36729513-37E07CE7-9960-47EB-A91B-3A6F18D5A194Q36782379-3F5088B9-391E-48E6-A998-7FE67BD92FF3Q36917897-FE997F41-A448-48BC-A036-A74A153518A8Q37223322-9238C181-20D1-4662-B32A-2A5A8BDCC79FQ37457838-3485800A-52E3-4862-97FA-F6F54C4B18C2Q37564540-624D094E-9C41-4867-A03E-5AE06CE8321DQ37603491-CC46946C-19BE-4B0F-9F19-4242E74CF158Q37706054-0C5E3CB6-3076-408C-8C2D-3F2E7D7F1D25Q37713683-28C415E1-6180-458D-9D52-1E6CFE2E26F1Q37726141-FF441884-BB8C-4147-8B23-150701682221Q38736395-162CC4E8-012D-4866-82A2-C8EE9617C9FBQ39169603-D4E725B1-D03D-4F1D-AE50-71CF60DCF65BQ39429469-60847298-498F-4B31-AD20-7EA86943211DQ47133116-2E53FB13-FB22-4444-8CDB-1376395976BCQ47292144-8A39D02E-95DB-408A-B019-926D163B1CA2Q47312809-3AA05B9F-94D7-4097-BDB5-888D649AF0E1Q48109847-9F734C66-6A3A-498A-B0A7-4D1A6600FB04Q48278671-2C739EBC-19A2-49B8-B1CA-E90CCFB8395DQ49843400-38C4E3E8-890F-4C2A-B128-A4C99392DF6FQ50961642-979426B8-1F6A-4BCD-9357-084455AC6E7D
P2860
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@ast
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@en
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@nl
type
label
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@ast
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@en
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@nl
prefLabel
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@ast
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@en
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
@nl
P2093
P2860
P50
P356
P1476
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
@en
P2093
Andras Ladanyi
Andrew P Mazar
Anthony Montag
Carla V Penicka
Chun-Yi Chiang
Elizabeth M Schryver
Erin A White
Hilary A Kenny
Joshy George
Karl Matlin
P2860
P304
P356
10.1172/JCI74778
P407
P577
2014-09-09T00:00:00Z